Global Medical REIT (NYSE:XRN) CEO Purchases $246,950.00 in Stock

Global Medical REIT Inc. (NYSE:XRN) CEO Mark Okey Decker, Jr. bought 6,875 shares of Global Medical REIT stock in a transaction dated Tuesday, August 11th. The stock was acquired at an average price of $35.92 per share, for a total transaction of $246,950.00. Following the completion of the acquisition, the chief executive officer owned 75,199 shares in the company, valued at approximately $2,701,148.08. The trade was a 10.06% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink.

Global Medical REIT Stock Up 1.9%

Shares of NYSE:XRN opened at $37.28 on Friday. The company has a current ratio of 0.59, a quick ratio of 0.68 and a debt-to-equity ratio of 1.37. Global Medical REIT Inc. has a 12 month low of $29.05 and a 12 month high of $39.93. The company has a 50-day moving average price of $36.62 and a 200 day moving average price of $35.81. The company has a market cap of $493.59 million, a price-to-earnings ratio of 10.02 and a beta of 1.09.

Global Medical REIT (NYSE:XRN) last released its quarterly earnings results on Wednesday, August 5th. The company reported $4.78 EPS for the quarter, topping the consensus estimate of $0.83 by $3.95. Global Medical REIT had a return on equity of 13.31% and a net margin of 36.82%.The company had revenue of $39.75 million during the quarter. As a group, equities research analysts predict that Global Medical REIT Inc. will post 2.89 earnings per share for the current year.

Trending Headlines about Global Medical REIT

Here are the key news stories impacting Global Medical REIT this week:

• Positive Sentiment: CEO Mark Okey Decker, Jr. bought 8,000 shares at $35.88 and an additional 6,875 shares at $35.92, while COO Aaron Robert Roseth purchased 13,500 shares at $36.73. Director Charles Fitzgerald also acquired 14,000 shares at $35.78. The reported purchases represent more than $1.5 million of direct insider buying, a potentially bullish signal. Global Medical REIT CEO Purchases Shares
• Positive Sentiment: Global Medical REIT’s latest quarterly results significantly exceeded expectations: earnings per share were $4.78 versus the $0.83 consensus estimate, with revenue of $39.75 million. The company also reported a 36.82% net margin and 13.74% return on equity, providing fundamental support for investor interest.
• Neutral Sentiment: Analyst opinion remains mixed, with two Buy ratings, five Holds and one Sell. The average price target is $40.25, above the recent trading range, but Compass Point maintains a $38 target while Citizens JMP has a $42 target. The overall consensus rating is Hold.
• Neutral Sentiment: Institutional investors own approximately 57.52% of XRN. Recent filings show several funds increasing positions, although the disclosed transactions are not necessarily a near-term catalyst.
• Neutral Sentiment: Coverage also discusses Global Medical REIT’s rebranding and transition to Chiron Real Estate, which may create uncertainty about the company’s identity and strategic direction. Chiron Real Estate rebrand article
• Negative Sentiment: The REIT remains relatively leveraged, with a debt-to-equity ratio of 1.68 and current and quick ratios of 0.68. High debt and limited liquidity could weigh on valuation if interest rates stay elevated or healthcare property conditions weaken.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of XRN. Marshall Wace LLP lifted its stake in shares of Global Medical REIT by 0.8% during the 4th quarter. Marshall Wace LLP now owns 38,244 shares of the company’s stock worth $1,290,000 after acquiring an additional 308 shares during the last quarter. Daiwa Securities Group Inc. grew its position in Global Medical REIT by 7.4% in the 4th quarter. Daiwa Securities Group Inc. now owns 4,827 shares of the company’s stock valued at $163,000 after acquiring an additional 332 shares during the last quarter. Fifth Third Bancorp grew its position in Global Medical REIT by 35.3% in the 4th quarter. Fifth Third Bancorp now owns 1,417 shares of the company’s stock valued at $48,000 after acquiring an additional 370 shares during the last quarter. Caitong International Asset Management Co. Ltd increased its stake in Global Medical REIT by 1,001.4% in the third quarter. Caitong International Asset Management Co. Ltd now owns 793 shares of the company’s stock worth $27,000 after purchasing an additional 721 shares during the period. Finally, Virtus Advisers LLC increased its stake in Global Medical REIT by 46.5% in the fourth quarter. Virtus Advisers LLC now owns 2,418 shares of the company’s stock worth $82,000 after purchasing an additional 768 shares during the period. Institutional investors own 57.52% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts recently weighed in on the company. Zacks Research upgraded Global Medical REIT to a “hold” rating in a report on Wednesday, July 22nd. Compass Point reaffirmed a “neutral” rating and set a $38.00 price objective (down from $50.00) on shares of Global Medical REIT in a research note on Thursday, May 7th. BMO Capital Markets boosted their price objective on shares of Global Medical REIT from $39.00 to $40.00 and gave the company a “market perform” rating in a research report on Monday, July 13th. Wall Street Zen cut shares of Global Medical REIT from a “hold” rating to a “sell” rating in a research report on Saturday, May 9th. Finally, Citizens Jmp increased their target price on shares of Global Medical REIT from $40.00 to $42.00 and gave the company a “market outperform” rating in a research note on Tuesday, May 26th. Two analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Global Medical REIT has a consensus rating of “Hold” and a consensus target price of $40.25.

Global Medical REIT Company Profile

Global Medical REIT (NYSE: GMRE) is a real estate investment trust focused on owning and managing healthcare-related properties across the United States. The company acquires, develops and leases a diversified portfolio of medical office buildings, outpatient facilities, long-term care centers and other specialized healthcare real estate. By concentrating on essential healthcare assets, Global Medical REIT seeks to generate stable, long-term rental income under triple-net and modified gross lease structures.

Since its incorporation in 2016 and initial public offering in 2017, the company has pursued an acquisitive growth strategy targeting markets with strong demographic trends and limited supply of modern medical facilities.